Recent

% | $
Quotes you view appear here for quick access.

Market Vectors Junior Gold Miners ETF Message Board

jrdelane 414 posts  |  Last Activity: Jun 24, 2016 9:19 AM Member since: Dec 5, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    MRNS shed $2 in 3 weeks...more to come?

    by visionaryabove May 12, 2016 2:03 PM
    jrdelane jrdelane May 14, 2016 12:12 AM Flag

    From 3:15 to 3:45 today, we had 30,000 shares sold, 20,000 in the first 15 minutes and 10,000 in the next 15 mintues, with the last 15 minutes being buying volume of 17,840 shares. That could have been a retail investor who needed to raise cash rather than someone acting on non-public inform.

  • Reply to

    Market cap less cash is about $40MM

    by mkforrest May 13, 2016 8:30 PM
    jrdelane jrdelane May 14, 2016 12:02 AM Flag

    From March 21 to today's drop, this stock has lost 35.8% of it's market cap to the $40MM you stated. There is no news, huge manipulation. Why the sudden drop from 3 pm to 3:30 pm today. Everywhere I look stocks are being shorted into oblivion. Last night I saw 'Money Monster' in the theatre, highlighting greed and illegal manipulation on Wall Street. Stock behavior, particularly in this sector and with small caps, has run rampantly out of control. Today I decided there's no new money going into another biotech stock. I will hold what I have and hopefully extricate myself and wait for a better market to develop. I have already started taking positions in other sectors, because right now our sector might as well be toxic, the chances of success are so against retail investors here.

  • Reply to

    Question for long-time longs

    by jrdelane May 13, 2016 2:35 PM
    jrdelane jrdelane May 13, 2016 11:43 PM Flag

    Quite a list for MultiStem, never knew about TBI or SCI, and maybe UC will make a repeat appearance in years to come?

  • Reply to

    Question for long-time longs

    by jrdelane May 13, 2016 2:35 PM
    jrdelane jrdelane May 13, 2016 5:25 PM Flag

    "The only real trial failure was run by Pfizer for UC." How is that important here, can you elaborate on the significance of that to Athersys's current plans?

  • Reply to

    Question for long-time longs

    by jrdelane May 13, 2016 2:35 PM
    jrdelane jrdelane May 13, 2016 5:20 PM Flag

    Very astute, thanks for your considerable reply! I completely agree one should understand all these things, but few take the time to be so well thought out. I have rushed ahead and am putting on the brakes now. If this launches like I think it will, I already have enough shares, but do have dry powder as well. I inquired via the company website to IR today to query the implications of the more robust larger trial and how that might affect the timeline to the hoped for approval.

    Sentiment: Strong Buy

  • Reply to

    Friday the 13th

    by jrdelane May 12, 2016 6:31 PM
    jrdelane jrdelane May 13, 2016 3:32 PM Flag

    It just turned ugly on us. Can't we just get this over with? Is it the sector, the lack of news, shorts, or all of the above. I have given up on charts here.

  • Given my short term perspective of only being here just over a month, I'd appreciate your opinion. After the disappointing market reaction to the trial last April, and now with the resurgence of the stock and new partnership, are you still buying at these levels? I have been buying even today, but we may continue to drip down with the consistent pressure of the short trade. I would imagine that there hasn't been a more exciting time to be in the stock, ever, with what is happening in Japan and with Healios. That being said, where do you see the stock in a month or two? My tendency is to get too excited and accumulate ahead of the curve, so would like to see what you see going forward. Thanks to serious replies only.

  • jrdelane jrdelane May 13, 2016 10:07 AM Flag

    I doubt the capacity of Healios to do even a leveraged buyout of Athersys, they are still a young company, they have debt, are not yet profitable. Healios has an option to expand the partnership on two indications, one not yet disclosed. It is less likely of a third party wanting to buy Athersys when they would be in partnership with Athersys on several indications. I think the partnership with Healios will continue to bear fruit as I_S gets further along and after PMDA approval, our value catapults, putting a buyout less likely for Healios.

  • jrdelane jrdelane May 12, 2016 7:40 PM Flag

    Really? I think it would be far better and cheaper for Healios to just continue to expand the partnership and keep our team in place, we don't need a buyout, we have the platform and the manufacturing, why would Gil and Company take a buyout, I don't see it being easily accomplished once PMDA approval is given, because it further validates the rest of the pipeline indications. It does beg the question, though, what is the depth of financial capability in Healios? Their quarterly report is now posted on their website as I posted earlier today, anyone? This Company Athersys is going to quickly become a several $billion company.

  • jrdelane jrdelane May 12, 2016 7:31 PM Flag

    What is your opinion on timing now that Healios and Athersys have agreed on a more robust trial with perhaps 100-200 participants in as many as 4+ trial sites? Will there be an interim data readout that could qualify for PMDA conditional or full approval based on their new expedited laws for approval?

  • From the you tube video entitled "R and D Partnership Day", /watch?v=rviLNOExY0Q.

    I love the statement by Hardy T.S. Kagimoto, President and Executive Director of Healios. "I think this is a moment we can create a company like Amgen or Genentech. What you need is... you have to be there at the birth of a new class of therapy, and this is a moment." If you haven't watched this video, it is a must see.

    Moderator Jason Kolbert handles himself with great poise, skill and intellect, with considerable enthusiasm. "We're looking at the potential for Athersys to move at a pace that none of us seem to be expecting, certainly the value of the stock in the marketplace doesn't expect. And pending that data release, you could see MultiStem unlocked to become a very, very big product."

    Athersys and Healios, "the potential to change medicine as we know it." Jason Kolbert.
    "We think that by working together, we can achieve that." Dr. Gil Van Bakken

  • Longs, I had a bid for shares this afternoon at 2.18 and it didn't get filled. Mid morning I think it traded below $2.20 but not for long. Closing at 2.23 when yesterday we closed at 2.29. I'd like to see the floor set in concrete at 2.20, no closes below it, can we all agree not to let these HFT programs work it lower? I know it's hard to control, really we don't have any control, but think hard about that floor, and let's see if we can't will it to be. Enough of us thinking that and you might be surprised how effective a mind set can be. GLAL.

  • jrdelane by jrdelane May 12, 2016 6:31 PM Flag

    I see tomorrow is the 13th, uh oh. I don't believe in this day being bad, so let's hope we see something positive. I also see we may have another reversal on our hands, from mid session today with follow through tomorrow? The Dow Industrials and the S&P 500 both had reversals today as well off of the 50-dma's. That is a good sign, maybe these last three weeks are what was needed to go to all time highs? I'm not saying it is going to happen, actually it is against the odds IMHO

  • Reply to

    MRNS shed $2 in 3 weeks...more to come?

    by visionaryabove May 12, 2016 2:03 PM
    jrdelane jrdelane May 12, 2016 6:20 PM Flag

    OK, don't look, remember? Interesting that both AVXL and MRNS have shed one third of their value (+-) from mid $6 range to $4/mid-$4 rangein the last 3 weeks. IBB is either going to test the January lows or break down altogether. XBI along with it. Hate this market. VA, I took a 51% profit out of GALE yesterday at $1.30 out.

  • jrdelane jrdelane May 12, 2016 4:31 PM Flag

    Thanks Bourbon, confirming that for decades now the drugs were targeting the by-product and not "upstream" as Missling points out is the difference in approach used by Anavex. The market forces are thrashing our stock now but those who understand and keep their shares through all this nonsense will be thrilled in a few years with their decision.

  • Reply to

    I dislike these investor conferences...

    by ranger43a May 12, 2016 10:15 AM
    jrdelane jrdelane May 12, 2016 1:02 PM Flag

    Anything biotech is getting crushed this week. I traded out of HZNP this morning flat as I saw it heading toward my basis. Across the board today down big, ETF's IBB and XBI are approaching their January lows. This sector isn't a friendly place to be this year. The last three weeks have been especially brutal. I also sold my GALE shares yesterday for a nice 50%+ profit. There have been few profits this year, that was an obvious one to take. We need more than good luck

  • On the landing page on their website wwwDOThealiosDOTcoDOTjp/en you will find they added their first quarter report of financial condition and update, which you can download in PDF. Athersys is prominently visible throughout as we are now a very important partner in their game plan, clearly their vision is worldly, as you will see. It's clear now to understand the enormous potential once you pour over this report.

  • Reply to

    svmlf relisted

    by alicesmoney Apr 18, 2016 3:47 PM
    jrdelane jrdelane May 12, 2016 1:27 AM Flag

    The US markets are so manipulated, it's getting to the point of why bother investing, particularly in any market that isn't an outright bull. Shorts are killing the biotech sector, innovation will end if they continue. Too many companies are being forced out of business, their stocks have been so brutally shorted.

  • "Healios will, in addition to the compound drug field, position ourselves as a core company in the field of regenerative medicine products that utilize iPS cell technologies. We will build cooperative relationships with leading research institutes, universities and businesses around the world for the research and development of drugs and regenerative medicine products." wwwDOThealiosDOTcoDOTjp/en/message/transition/

    As regards the expansion of the partnership to include other indications, and other markets, watching the videos carefully, taking the many statements offered by Gil and Hardy, and projecting their own vision statement forward, the likelihood of Athersys becoming fully integrated as a worldwide partner of Healios seems more than likely, just a question of time IMHO.

  • Reply to

    Gap Filled now we right the Ship

    by success_now62 May 11, 2016 9:42 AM
    jrdelane jrdelane May 11, 2016 12:26 PM Flag

    Seems right, let's see how she sails.

GDXJ
41.76+1.98(+4.98%)Jun 24 4:52 PMEDT